On November 30, 2023, BrightPath Biotherapeutics Co., Ltd. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
60 JPY | 0.00% | +3.45% | -31.03% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
185.5 AUD | -1.05% | -1.78% | 44.85B | ||
60 JPY | 0.00% | +3.45% | 26.64M | ||
1st Jan change | Capi. | |
---|---|---|
-31.03% | 26.64M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- 4594 Stock
- News BrightPath Biotherapeutics Co., Ltd.
- BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited